Market research reports, consulting: Global Market Insights Inc.
We use cookies to enhance user experience. (Privacy Policy)

External Defibrillators Market Analysis

Report ID: GMI6648
   |
Published Date: September 2023
 | 
Report Format: PDF

Download free sample

External Defibrillator Market Analysis

External Defibrillators Market Size, By Product

Based on product, the external defibrillator market is segmented as manual external defibrillator, automated external defibrillator, and wearable external cardioverter defibrillator. The automated external defibrillator segment held considerable revenue share in 2022 and is projected to expand at 7.5% CAGR to reach USD 2.4 billion by 2032. This segmental growth is majorly attributed to the increasing adoption of these devices, technological advancements driving easy use & automation, and surged prevalence of out-of-hospital cardiac arrest (OHCA). Out-of-hospital cardiac arrest is amongst the significant variables responsible for mortality and morbidity. According to the article published in the American Heart Journals, in 2018, around 50,000 OHCAs were reported in the U.S. External defibrillators are crucial medical devices used in such out-of-hospital cardiac arrest situations.
 

Moreover, automated external defibrillator is designed to be used by non-medical professionals, such as bystanders and first responders. They often provide simple and clear audio & visual instructions, guiding users through the defibrillation process. It allows for immediate intervention in cases of sudden cardiac arrest. Quick defibrillation is crucial to restoring a normal heart rhythm and improving the chances of survival. They are portable devices, making them suitable for a variety of settings, including public spaces, offices, schools, and airports among others. Their compact size ensures they can be easily stored and accessed when needed. Many AED models provide real-time feedback to users during the resuscitation process. This feedback can include guidance on the quality of chest compressions, ensuring that effective CPR is being performed.
 

 External Defibrillators Market Share, By End-use,

Based on end-use, the external defibrillator market is segmented as hospitals, prehospital care, ambulatory surgical centers, and others. The hospitals segment held significant share in 2022 and is projected to reach more than USD 2.7 billion by 2032. The soaring use of novel external defibrillators in hospital settings delivering rapid and reliable outcomes is estimated to surge the patient preference for these healthcare facilities. The availability of a broad spectrum of external defibrillators for performing defibrillation treatment with proven accuracy is set to drive product preference in hospitals. Growing admissions with cardiac ailments and growing disease screening initiatives along with the accessibility to board-certified healthcare professionals are some other variables that are augmenting the segment growth positively.
 

Furthermore, the rising disease burden in developed economies with enhanced healthcare infrastructure is projected to stimulate the diagnosis & treatment rate at hospitals. As a result, accessibility to an effective treatment procedure coupled with the rising prevalence of cardiovascular diseases and associated conditions will boost the patient visits to hospitals, thereby propelling the segment revenue.
 

U.S. External Defibrillators Market Size

The U.S. external defibrillators market is anticipated to reach more than USD 2.1 billion by 2032. This significant market share is attributed to several factors such as the presence of major industry players, an upsurge in the demand for cardiovascular devices, rise in the prevalence of cardiovascular conditions, and growing number of hospital admissions across the country among others. As per the American Heart Association data 2022, the age adjusted death-rate attributable to cardiovascular diseases was 224.4 per 100,000 population.
 

Additionally, in 2020, coronary heart disease (41.2%) was the leading cause of deaths followed by stroke (17.3%), heart failure (9.2%), etc. in the U.S. These adverse events are anticipated to upsurge the adoption rate for better CVD management. This is further driving the entry of new players in the market that are projected to increase over the forecast timeframe. Moreover, the U.S. is one of the leading nations in terms of heart care initiatives and the government has employed several guidelines to bolster heart care comprising the Million Hearts initiative. These initiatives adopted by the public as well as private organizations would further promote the demand for external defibrillators in the management of certain aspects of heart disease.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo
Frequently Asked Question(FAQ) :
Why is the demand for automated external defibrillators growing?
Automated external defibrillator industry size will witness 7.5% CAGR from 2023-2032 on account of their increasing adoption to meet the surging prevalence of out-of-hospital cardiac arrest (OHCA).
How big is the external defibrillator market?
What factors are influencing external defibrillator market growth in the U.S.?
Who are the key external defibrillator industry players?
External Defibrillators Market Scope

Report Content

Chapter 1   Methodology & Scope

1.1    Industry coverage

1.2    Market scope & definitions

1.3    Base estimates & working

1.3.1    Data collection

1.4    Forecast parameters

1.5    COVID-19 impact at global level

1.6    Data validation

1.7    Data sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    External defibrillator industry 360synopsis, 2018 – 2032

2.2    Business trends

2.3    Regional trends

2.4    Product trends

2.5    End-use trends

Chapter 3   External Defibrillator Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Rising prevalence of cardiac diseases

3.2.1.2   Technological advancements and introduction of innovative devices

3.2.1.3   Increasing public awareness

3.2.1.4   Surging demand for wearable cardioverter defibrillators

3.2.2    Industry pitfalls & challenges

3.2.2.1   High cost of the devices

3.2.2.2   Product recalls

3.3    Growth potential analysis

3.3.1    By product

3.3.2    By end-use

3.4    COVID-19 impact analysis

3.5    Regulatory landscape

3.5.1    U.S.

3.5.2    Europe

3.6    Reimbursement scenario

3.7    Pricing analysis, 2022

3.8    Product pipeline analysis

3.9    Technology landscape

3.10    Startup scenario

3.11    Gap analysis

3.12    Porter’s analysis

3.13    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Company market share analysis, 2022

4.4    Competitive positioning matrix

4.5    Vendor matrix analysis

4.6    Strategy dashboard, 2022

Chapter 5   External Defibrillator Market Size and Forecast, By Product (USD Million & Units)

5.1    Key product trends

5.2    Manual External Defibrillator

5.3    Automated External Defibrillator

5.3.1    Semi-automated external defibrillator

5.3.2    Fully automated external defibrillator

5.4    Wearable External Cardioverter Defibrillator

Chapter 6   External Ddefibrillator Market Size and Forecast, By End-use (USD Million)

6.1    Key end-use trends

6.2    Hospitals

6.3    Prehospital Care

6.4    Ambulatory Surgical Centers

6.5    Others

Chapter 7   External defibrillator Market Size and Forecast, By Region (USD Million & Units)

7.1    Key regional trends

7.2    North America

7.2.1    U.S.

7.2.2    Canada

7.3    Europe

7.3.1    Germany

7.3.2    UK

7.3.3    France

7.3.4    Spain

7.3.5    Italy

7.3.6    Poland

7.4    Asia Pacific

7.4.1    China

7.4.2    Japan

7.4.3    India

7.4.4    Australia

7.4.5    South Korea

7.4.6    Indonesia

7.5    Latin America

7.5.1    Brazil

7.5.2    Mexico

7.5.3    Argentina

7.6    Middle East & Africa

7.6.1    South Africa

7.6.2    Saudi Arabia

7.6.3    UAE

Chapter 8   Company Profiles

8.1    Abbott Laboratories, Inc.

8.2    Boston Scientific Corporation

8.3    Koninklijke Philips

8.4    Stryker Corporation

8.5    Medtronic plc

8.6    LivaNova PLC

8.7    Asahi Kasei Corporation (ZOLL Medical Corporation)

8.8    Nihon Kohden Corporation

8.9    MicroPort Scientific Corporation

8.10    Element Science Inc.

8.11    AMI Italia

8.12    Bexen Cardio

8.13    BPL Medical Technologies

8.14    Corpuls

8.15    Schiller AG

   

Authors: Mariam Faizullabhoy , Shishanka Wangnoo
Buy Now
$4,123 $4,850
15% off
$4,280 $5,350
20% off
$5,845 $8,350
30% off
    Buy now
Premium Report Details

Base Year: 2022

Companies covered: 15

Tables & Figures: 334

Countries covered: 20

Pages: 180

Download Free Sample

Top